Recce Pharmaceuticals Ltd
ASX:RCE
Recce Pharmaceuticals Ltd
ASX:RCE
Price:
0.545
AUD
-3.54%
Market Closed
Market Cap:
AU$157.6m
Income Statement
Earnings Waterfall
Recce Pharmaceuticals Ltd
Recce Pharmaceuticals Ltd
Income Statement
Recce Pharmaceuticals Ltd
Recce Pharmaceuticals Ltd
Currency: AUD
| Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Revenue |
0
N/A
|
0
-55%
|
0
+137%
|
1
+207%
|
1
+123%
|
2
+19%
|
1
-56%
|
1
+58%
|
1
+6%
|
1
-30%
|
2
+146%
|
1
-35%
|
3
+147%
|
3
0%
|
4
+40%
|
7
+54%
|
5
-23%
|
10
+88%
|
8
-22%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(5)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(14)
|
(15)
|
(10)
|
(14)
|
(18)
|
(17)
|
(18)
|
(22)
|
(26)
|
(28)
|
|
| Selling, General & Administrative |
(5)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(12)
|
(14)
|
(7)
|
(12)
|
(14)
|
(16)
|
(15)
|
(20)
|
(19)
|
(25)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(4)
|
(1)
|
(2)
|
(1)
|
(7)
|
(2)
|
|
| Operating Income |
(5)
N/A
|
(2)
+52%
|
(3)
-35%
|
(3)
+10%
|
(2)
+40%
|
(2)
0%
|
(3)
-69%
|
(3)
-9%
|
(4)
-43%
|
(13)
-209%
|
(14)
-3%
|
(8)
+39%
|
(11)
-32%
|
(15)
-39%
|
(13)
+16%
|
(11)
+15%
|
(17)
-55%
|
(17)
+1%
|
(20)
-22%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
|
| Pre-Tax Income |
(5)
N/A
|
(2)
+54%
|
(3)
-37%
|
(3)
+10%
|
(2)
+39%
|
(2)
-1%
|
(3)
-65%
|
(3)
-10%
|
(4)
-41%
|
(13)
-205%
|
(14)
-3%
|
(8)
+39%
|
(11)
-32%
|
(15)
-39%
|
(13)
+14%
|
(11)
+13%
|
(18)
-56%
|
(18)
-2%
|
(21)
-19%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(5)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(13)
|
(14)
|
(8)
|
(11)
|
(15)
|
(13)
|
(11)
|
(18)
|
(18)
|
(21)
|
|
| Net Income (Common) |
(5)
N/A
|
(2)
+54%
|
(3)
-37%
|
(3)
+10%
|
(2)
+39%
|
(2)
-1%
|
(3)
-65%
|
(3)
-10%
|
(4)
-41%
|
(13)
-205%
|
(14)
-3%
|
(8)
+39%
|
(11)
-32%
|
(15)
-39%
|
(13)
+14%
|
(11)
+13%
|
(18)
-56%
|
(18)
-2%
|
(21)
-19%
|
|
| EPS (Diluted) |
-0.09
N/A
|
-0.01
+89%
|
-0.04
-300%
|
-0.03
+25%
|
-0.02
+33%
|
-0.02
N/A
|
-0.03
-50%
|
-0.03
N/A
|
-0.03
N/A
|
-0.1
-233%
|
-0.09
+10%
|
-0.06
+33%
|
-0.06
N/A
|
-0.08
-33%
|
-0.07
+12%
|
-0.06
+14%
|
-0.1
-67%
|
-0.09
+10%
|
-0.09
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
